Stocks VFC Financial statements
Financial statementsV F CORP financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data V F CORP files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,026 | 11,736 | 10,267 | 10,489 | 9,239 | 11,842 | 11,089 | 9,916 | 9,505 | 9,605 |
| Cost of revenue | 5,590 | 3,849 | 4,656 | 4,691 | 4,371 | 5,386 | 5,293 | 4,803 | 4,421 | 4,343 |
| Gross profit | 5,436 | 7,886 | 5,611 | 5,798 | 4,868 | 6,455 | 5,796 | 5,112 | 5,084 | 5,262 |
| Selling, general and administrative | 3,901 | 3,662 | 4,420 | 4,547 | 4,240 | 4,823 | 4,798 | 4,749 | 4,691 | 4,654 |
| Operating income | 1,455 | 883 | 1,190 | 928 | 608 | 1,632 | 999 | -144 | 304 | 577 |
| Interest expense | 0 | 102 | 108 | 92 | 136 | 136 | 174 | 245 | 174 | 167 |
| Interest income | 9.18 | 13 | 15 | 19.9 | 9.16 | 5.01 | 8.86 | 20.2 | 24.9 | 18 |
| Other non-operating income | -85.2 | -6.52 | -59.1 | -68.7 | -24.7 | 26.2 | -117 | 24.7 | -9.37 | -86.6 |
| Pre-tax income | 1,285 | 788 | 1,038 | 727 | 456 | 1,523 | 738 | -285 | 145 | 341 |
| Income tax | 206 | 520 | 168 | 98.1 | 102 | 307 | -17.9 | 734 | 75.8 | 86.3 |
| Income from continuing operations | 1,079 | 268 | 870 | 629 | 355 | 1,216 | 756 | -1,018 | 69.3 | 255 |
| Net income | 1,074 | 615 | 1,260 | 679 | 408 | 1,387 | 119 | -969 | -190 | 255 |
| EBITDA | 1,737 | 1,122 | 1,446 | 1,195 | 877 | 1,899 | 1,251 | 164 | 563 | 857 |
| EPS, basic | 2.58 | 1.54 | 3.19 | 1.72 | 1.05 | 3.55 | 0.31 | -2.49 | -0.49 | 0.65 |
| EPS, diluted | 2.54 | 1.52 | 3.15 | 1.70 | 1.04 | 3.53 | 0.31 | -2.49 | -0.48 | 0.64 |
| Shares, basic (weighted) | 416 | 399 | 395 | 395 | 390 | 390 | 388 | 388 | 389 | 391 |
| Shares, diluted (weighted) | 422 | 404 | 400 | 400 | 392 | 392 | 388 | 388 | 393 | 396 |
| Dividend per share | 1.53 | 1.72 | 1.94 | 1.90 | 1.94 | 1.98 | 1.81 | 0.78 | 0.36 | 0.36 |
Balance sheet
| FY2016 | FY2017 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,225 | 434 | 402 | 1,369 | 816 | 1,276 | 799 | 656 | 429 | 824 |
| Short-term investments | 0 | 599 | 0 | |||||||
| Receivables | 1,149 | 1,430 | 1,373 | 1,308 | 1,298 | 1,468 | 1,610 | 1,263 | 1,322 | 1,428 |
| Inventory | 1,425 | 1,707 | 1,173 | 1,294 | 1,062 | 1,419 | 2,293 | 1,698 | 1,627 | 1,371 |
| Other current assets | 294 | 297 | 426 | 445 | 424 | 426 | 435 | 493 | 408 | 386 |
| Total current assets | 4,293 | 4,378 | 4,673 | 5,027 | 4,786 | 4,588 | 5,153 | 4,227 | 3,786 | 4,010 |
| Property, plant and equipment | 896 | 1,015 | 876 | 954 | 976 | 1,042 | 911 | 789 | 721 | 675 |
| Lease right-of-use assets | 0 | 1,274 | 1,474 | 1,247 | 1,306 | 1,255 | 1,262 | 1,321 | ||
| Goodwill | 1,555 | 1,693 | 1,492 | 1,156 | 2,425 | 2,394 | 1,156 | 645 | 603 | 588 |
| Intangible assets | 1,534 | 2,090 | 1,907 | 1,855 | 3,030 | 3,000 | 2,643 | 1,776 | 1,711 | 1,468 |
| Other non-current assets | 922 | 784 | 768 | 868 | 1,063 | 1,071 | 1,902 | 1,210 | 1,294 | 1,230 |
| Total assets | 9,739 | 9,959 | 10,357 | 11,133 | 13,754 | 13,342 | 13,990 | 11,613 | 9,378 | 9,290 |
| Accounts payable | 620 | 761 | 490 | 407 | 463 | 563 | 936 | 788 | 790 | 826 |
| Accrued liabilities | 812 | 1,147 | 1,125 | 1,260 | 1,610 | 1,916 | 1,674 | 1,324 | 1,047 | 1,011 |
| Deferred revenue | 49.9 | 71.1 | 62.2 | 66.1 | 78.4 | 76.9 | ||||
| Short-term debt | 250 | 0 | 670 | 0 | 0 | 500 | 923 | 1,000 | 540 | 0 |
| Total current liabilities | 1,785 | 2,744 | 2,662 | 3,024 | 2,210 | 3,315 | 3,546 | 3,457 | 2,698 | 2,181 |
| Long-term debt | 2,025 | 2,152 | 2,087 | 2,586 | 5,691 | 4,567 | 5,695 | 4,687 | 3,412 | 3,520 |
| Lease liabilities | 0 | 1,021 | 1,236 | 1,024 | 1,172 | 1,087 | 1,079 | 1,120 | ||
| Other non-current liabilities | 886 | 1,307 | 1,235 | 1,123 | 1,542 | 888 | 651 | 636 | 687 | 619 |
| Total liabilities | 4,798 | 6,239 | 6,058 | 7,776 | 10,698 | 9,812 | 11,080 | 9,955 | 7,890 | 7,440 |
| Total debt | 2,275 | 2,152 | 2,087 | 2,586 | 5,691 | 5,067 | 6,618 | 5,687 | 3,951 | 3,520 |
| Paid-in capital | 3,333 | 3,523 | 3,922 | 4,184 | 3,778 | 3,916 | 3,776 | 3,600 | 3,541 | 3,488 |
| Retained earnings | 2,545 | 1,024 | 1,180 | 7.31 | 190 | 443 | 57.1 | -975 | -1,173 | -929 |
| Other comprehensive income | -1,041 | -926 | -902 | -931 | -1,009 | -927 | -1,020 | -1,064 | -978 | -807 |
| Shareholders' equity | 4,941 | 3,720 | 4,299 | 3,357 | 3,056 | 3,530 | 2,911 | 1,658 | 1,487 | 1,850 |
| Total equity | 4,941 | 3,720 | 4,299 | 3,357 | 3,056 | 3,530 | 2,911 | 1,658 | 1,487 | 1,850 |
| Total liabilities and equity | 9,739 | 9,959 | 10,357 | 11,133 | 13,754 | 13,342 | 13,990 | 11,613 | 9,378 | 9,290 |
| Shares outstanding | 414 | 396 | 397 | 389 | 392 | 388 | 389 | 389 | 390 | 392 |
Cash flow statement
| FY2016 | FY2017 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 1,074 | 615 | 1,260 | 679 | 408 | 1,387 | 119 | -969 | -190 | 255 |
| Depreciation and amortization | 282 | 238 | 256 | 268 | 269 | 267 | 252 | 308 | 260 | 281 |
| Stock-based compensation | 67.8 | 63.9 | 84.3 | 68.2 | 70.8 | 91.4 | 40 | 57.8 | 73.2 | 77 |
| Deferred income tax | -71.6 | -80.6 | -48 | -74.5 | -39.8 | -157 | 12.4 | -384 | -88.5 | -42.2 |
| Change in receivables | 47.1 | -39.2 | -311 | -5.95 | 70.5 | -203 | -142 | 324 | -101 | -167 |
| Change in inventory | -37.2 | 38.6 | -58.7 | -141 | 314 | -381 | -883 | 521 | 54.1 | 174 |
| Cash from operations | 1,481 | 1,475 | 1,664 | 875 | 1,313 | 864 | -656 | 1,015 | 465 | 671 |
| Capital expenditures | -176 | -140 | -216 | -288 | -199 | -245 | -152 | -136 | -86.3 | -115 |
| Acquisitions | 0 | -741 | -320 | 0 | -2,009 | 3.76 | 0 | 0 | ||
| Purchases of investments | 0 | 0 | -800 | 0 | 0 | |||||
| Cash from investing | -112 | -776 | -221 | -302 | -2,896 | 904 | -188 | -172 | 1,428 | 407 |
| Debt issued | 952 | 0 | 0 | 1,077 | 2,996 | 0 | 2,058 | 0 | 0 | |
| Debt repaid | -13.3 | -254 | -6.26 | -649 | -1.66 | -504 | -501 | -908 | -1,751 | -583 |
| Share buybacks | -1,000 | -1,200 | -151 | -1,000 | 0 | -350 | 0 | 0 | ||
| Dividends paid | -636 | -685 | -767 | -749 | -757 | -773 | -703 | -303 | -140 | -141 |
| Cash from financing | -1,077 | -1,363 | -1,591 | 310 | 1,053 | -1,269 | 464 | -960 | -2,146 | -738 |
| Exchange rate effect | -6.65 | 2.97 | 14.8 | -27.5 | ||||||
| Net change in cash | 285 | -662 | -133 | 855 | -560 | 426 | -461 | -139 | -245 | 401 |
| Free cash flow | 1,305 | 1,334 | 1,448 | 586 | 1,115 | 619 | -808 | 879 | 379 | 557 |
| Interest paid | 87.5 | 99.9 | 103 | 76.5 | 89.8 | 123 | 139 | 176 | 163 | 145 |
| Income taxes paid | 435 | 331 | 360 | 287 | 188 | 264 | 1,114 | 350 | 163 | 172 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 54.8% | Gross profit / revenue. |
| Operating margin | 6.0% | Operating income / revenue. |
| EBITDA margin | 8.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 3.6% | Pre-tax income / revenue. |
| Net margin | 2.7% | Net income / revenue. |
| FCF margin | 5.8% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 7.0% | Cash from operations / revenue. |
| Effective tax rate | 25.3% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 15.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 2.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | 9.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 48.5% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.8% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.2% | Capital expenditures / revenue. |
| D&A / revenue | 2.9% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 1.1% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -4.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 0.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 3.5% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -3.2% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 1.6% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 89.8% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -16.7% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | -1.0% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 52.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -11.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -0.5% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income CAGR, 3y | 29.1% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -9.0% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS CAGR, 3y | 27.3% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -9.3% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 44.3% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 5y | -12.6% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 46.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 5y | -13.0% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 0.0% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | -41.6% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share CAGR, 5y | -28.6% | Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 24.4% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -14.0% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | -9.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -0.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -12.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -7.5% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 0.2% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.84x | Current assets / current liabilities. |
| Quick ratio | 1.03x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.38x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 1.90x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 37.9% | Total debt / total assets. |
| Liabilities / assets | 80.1% | Total liabilities / total assets. |
| Net debt | $2.70B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 3.15x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 3.46x | Operating income / interest expense. |
| Working capital | $1.83B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 22.1% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$205.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.03x | Revenue / average total assets. |
| Fixed asset turnover | 13.8x | Revenue / average property, plant and equipment. |
| Inventory turnover | 2.90x | Cost of revenue / average inventory. |
| Days inventory | 126 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 6.99x | Revenue / average receivables. |
| Days sales outstanding | 52 days | 365 x average receivables / revenue. |
| Days payables | 68 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 110 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 218.3% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 17.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.64 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.65 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $24.26 | Revenue / diluted weighted shares. |
| FCF per share | $1.41 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.70 | Cash from operations / diluted weighted shares. |
| Book value per share | $4.72 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$0.52 | Tangible book value / shares outstanding. |
| Cash per share | $2.10 | (Cash + short-term investments) / shares outstanding. |
| Dividend per share | $0.36 | Dividend declared per common share (paid, when declared is not tagged). |
| Payout ratio | 55.2% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 25.3% | Dividends paid / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $5.56B | Share price x shares outstanding. |
| Enterprise value | $8.26B | Market cap + total debt - cash - short-term investments. |
| P/E | 21.8x | Market cap / net income. Only when net income is positive. |
| P/S | 0.58x | Market cap / revenue. |
| P/B | 3.01x | Market cap / shareholders' equity. Only when equity is positive. |
| P/FCF | 9.99x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 8.29x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.86x | Enterprise value / revenue. |
| EV/EBIT | 14.3x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 9.64x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 14.8x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 10.0% | Free cash flow / market cap. |
| Earnings yield | 4.6% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 2.5% | Dividends paid over the period / market cap. |
| Shareholder yield | 2.5% | (Dividends paid + share buybacks) / market cap. |
| PEG | 0.80x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was V F CORP's revenue in fiscal 2026?
V F CORP reported revenue of $9.61B for fiscal 2026, 1.1% higher than the year before.
Was V F CORP profitable in fiscal 2026?
Yes. Net income was $254.9M, a net margin of 2.7%.
How much free cash flow did V F CORP generate in fiscal 2026?
Cash from operations of $671.3M minus capital expenditures of $114.7M left free cash flow of $556.6M.